Neuroprotective actions of GLP-1 receptor agonists: an emerging role in antidepressant therapy
GLP-1 medications are not quick fixes
Im really excited about that because it suggests the potential for individual differences in the central GLP-1 system that could be attributed to dietary effects or perhaps stress exposures early in development, she said
Am J Phys 260(1 Pt 1):E67E74 Janssen MM, Snoek FJ, Heine RJ (2000) Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia
Some patch ingredients (berberine, green tea catechins) have shown modest GLP-1 signaling effects in animal models with oral dosing at gram-level quantities
This same principle applies when comparing semaglutide, tirzepatide, and future medications such as retatrutide